Pfizer Ventures (US) LLC
Insider CIK 1776087 · CRTX 10% owner · IMRA 10% owner · SWTX 10% owner · PYXS 10% owner · BCAB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology, Inc. | P Buy | 2023-03-17 | 2023-03-21 | 1,811,594 | $2.76 | $5.00M | 5,952,263 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | P Buy | 2023-03-17 | 2023-03-23 | 1,811,594 | $2.76 | $5.00M | 5,952,263 | SEC↗ |
| BCAB BioAtla, Inc. | C Conversion deriv | 2020-12-18 | 2020-12-22 | 2,238,090 | — | $0 | 0 | SEC↗ |
| BCAB BioAtla, Inc. | C Conversion | 2020-12-18 | 2020-12-22 | 2,238,090 | — | $0 | 2,238,090 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2020-06-03 | 2020-06-04 | 370,000 | $40.18 | $14.87M | 2,879,973 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,470,492 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 478,749 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,894,444 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 300,752 | — | $0 | 1,169,219 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 868,467 | — | $0 | 868,467 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 76,003 | — | $0 | 76,003 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 312,500 | $16.00 | $5.00M | 1,481,719 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 6,437,500 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 3,465,571 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 20,000,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 3,039,051 | — | $0 | 4,017,245 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 978,194 | — | $0 | 978,194 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 526,602 | — | $0 | 4,543,847 | SEC↗ |
| SWTX SpringWorks Therapeutics, | P Buy | 2019-09-17 | 2019-09-19 | 50,000 | $18.00 | $900.0K | 4,593,847 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-14 | 624,205 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-14 | 215,697 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-14 | 2,360,071 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-14 | 2,360,071 | — | $0 | 2,360,071 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2019-05-13 | 2019-05-14 | 50,000 | $17.00 | $850.0K | 3,249,973 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-14 | 624,205 | — | $0 | 3,199,973 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-14 | 215,697 | — | $0 | 2,575,768 | SEC↗ |